Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment

NCT02982642 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor cannot conduct research due to insufficient funding supportment

Conditions

Mild Cognitive Impairment

Interventions

DRUG: 1612 capsule
DRUG: Placebos

Sponsor

Dongzhimen Hospital, Beijing